|
US20020164350A1
(en)
|
1992-09-03 |
2002-11-07 |
Lowy Douglas R. |
Chimeric papillomavirus-like particles
|
|
US8062642B1
(en)
|
1993-03-09 |
2011-11-22 |
University Of Rochester |
Production of papillomavirus capsid protein and virus-like particles
|
|
AU4270196A
(en)
*
|
1994-10-07 |
1996-05-02 |
Lutz Gissmann |
Papilloma virus-like particles, fusion proteins and process for producing the same
|
|
CA2257822A1
(en)
|
1996-07-17 |
1998-01-22 |
The Government Of The United States Of America, Represented By The Secre Tary, Department Of Health And Human Services |
Infectious papillomavirus pseudoviral particles
|
|
DE19631357A1
(de)
*
|
1996-08-02 |
1998-02-05 |
Deutsches Krebsforsch |
Vektor zur Aktivierung des Immunsystems gegen mit Papillomviren bzw. Sequenzen davon assoziierten Zellen
|
|
GB9621091D0
(en)
|
1996-10-09 |
1996-11-27 |
Fondation Pour Le Perfectionem |
Attenuated microorganisms strains and their uses
|
|
ATE341339T1
(de)
*
|
1996-12-20 |
2006-10-15 |
Merck & Co Inc |
Zusammensetzungen von rekombinanten papillomavirus vakzinen
|
|
WO1999001557A1
(en)
*
|
1997-07-03 |
1999-01-14 |
University Of Colorado, University Technology Corporation |
Homogeneous human papilloma virus capsomere containing compositions, methods for manufacture, and the use thereof as diagnostic, prophylactic or therapy
|
|
US7351533B2
(en)
*
|
1997-09-05 |
2008-04-01 |
Medimmune, Inc. |
In vitro method for disassmbly/reassembly of papillomavirus virus-like particles (VLPs). Homogeneous VLP and cavsomere compositions produced by said methods: use thereof as vehicle for improved purification, and delivery of active agents
|
|
US6228368B1
(en)
|
1997-10-06 |
2001-05-08 |
Loyola University Of Chicago |
Papilloma virus capsomere formulations and method of use
|
|
AU2003200653B2
(en)
*
|
1997-10-06 |
2007-01-18 |
Loyola University Of Chicago |
Papilloma virus capsomere vaccine formulations and methods of use
|
|
US7182947B2
(en)
|
1998-02-20 |
2007-02-27 |
Medigene Ag |
Papillomavirus truncated L1 protein and fusion protein constructs
|
|
US7494658B2
(en)
*
|
1998-02-20 |
2009-02-24 |
Medigene Ag |
Papilloma virus truncated L1 protein and fusion protein constructs
|
|
US20020039584A1
(en)
|
1998-02-20 |
2002-04-04 |
Medigene Ag |
Papilloma virus capsomere vaccine formulations and methods of use
|
|
CA2229955C
(en)
|
1998-02-20 |
2003-12-09 |
Medigene Gmbh |
Papilloma virus capsomere vaccine formulations and methods of use
|
|
DE19812940A1
(de)
*
|
1998-03-24 |
1999-10-07 |
Medigene Ag |
Formulierung mit Papillomavirus-spezifischem Protein, seine Herstellung und Verwendung
|
|
US6926897B1
(en)
*
|
1998-03-24 |
2005-08-09 |
Medigene Aktiengesellschaft |
Medicament for the avoidance or treatment of papillomavirus-specific tumour
|
|
GB9806666D0
(en)
*
|
1998-03-27 |
1998-05-27 |
Stanley Margaret |
Antigen preparation and use
|
|
US6991795B1
(en)
*
|
1998-08-14 |
2006-01-31 |
Merck & Co., Inc. |
Protein delivery system using human papillomavirus virus-like particles
|
|
JP4563582B2
(ja)
*
|
1998-08-14 |
2010-10-13 |
メルク・シャープ・エンド・ドーム・コーポレイション |
ヒトパピローマウイルスのウイルス様粒子を使用するタンパク質送達系
|
|
EP1797896A1
(en)
|
1998-10-16 |
2007-06-20 |
GlaxoSmithKline Biologicals SA |
Adjuvant systems and vaccines
|
|
SE514982C2
(sv)
*
|
1999-09-30 |
2001-05-28 |
Active Biotech Ab |
Bärare innehållande ett huvudkapsidprotein L1 från humant papillomavirus samt dess användning
|
|
DE19925199A1
(de)
|
1999-06-01 |
2000-12-07 |
Medigene Ag |
Zytotoxische T-Zellepitope des Papillomavirus L1-Proteins und ihre Verwendung in Diagnostik und Therapie
|
|
DE19925235A1
(de)
|
1999-06-01 |
2000-12-07 |
Medigene Ag |
Zytotoxische T-Zellepitope des Papillomavirus L1-Proteins und ihre Verwendung in Diagnostik und Therapie
|
|
US20040146531A1
(en)
*
|
1999-09-30 |
2004-07-29 |
Active Biotech Ab |
Virus-like particles devoid of HPV 16 type-specific antibody epitopes as carriers of peptides for introduction into cells
|
|
US6908613B2
(en)
*
|
2000-06-21 |
2005-06-21 |
Medimmune, Inc. |
Chimeric human papillomavirus (HPV) L1 molecules and uses therefor
|
|
WO2002004007A2
(en)
*
|
2000-07-06 |
2002-01-17 |
Georgetown University |
Stable (fixed) forms of viral capsid proteins, fusion proteins and uses thereof
|
|
GB0109297D0
(en)
|
2001-04-12 |
2001-05-30 |
Glaxosmithkline Biolog Sa |
Vaccine
|
|
DE10137102A1
(de)
*
|
2001-07-30 |
2003-02-27 |
Deutsches Krebsforsch |
Polyvalente Vakzine gegen durch Papillomaviren verursachte Erkrankungen, Verfahren zu deren Herstellung und deren Verwendung
|
|
GB0206360D0
(en)
*
|
2002-03-18 |
2002-05-01 |
Glaxosmithkline Biolog Sa |
Viral antigens
|
|
PT1506222E
(pt)
*
|
2002-05-17 |
2009-06-12 |
Univ Cape Town |
Proteínas l1 quiméricas do papilomavírus humano 16 incluindo um péptido l2, partículas semelhantes a vírus preparadas a partir daquelas e um método de preparação das partículas
|
|
WO2004042001A2
(en)
*
|
2002-05-17 |
2004-05-21 |
Emory University |
Virus-like particles, methods of preparation, and immonogenic compositions
|
|
US9045727B2
(en)
*
|
2002-05-17 |
2015-06-02 |
Emory University |
Virus-like particles, methods of preparation, and immunogenic compositions
|
|
US7858098B2
(en)
*
|
2002-12-20 |
2010-12-28 |
Glaxosmithkline Biologicals, S.A. |
Vaccine
|
|
US20080160040A1
(en)
*
|
2004-04-15 |
2008-07-03 |
Ghim Shin-Je |
Plant-produced compositions for treating papillomavirus infection and related methods
|
|
US7732166B2
(en)
*
|
2005-11-15 |
2010-06-08 |
Oncohealth Corporation |
Detection method for human pappilomavirus (HPV) and its application in cervical cancer
|
|
US7972776B2
(en)
*
|
2005-11-15 |
2011-07-05 |
Oncohealth Corporation |
Protein chips for HPV detection
|
|
TWI457133B
(zh)
|
2005-12-13 |
2014-10-21 |
Glaxosmithkline Biolog Sa |
新穎組合物
|
|
US8778351B2
(en)
|
2006-08-30 |
2014-07-15 |
University Of Rochester |
Combined human papillomavirus VLP/gene delivery system and use thereof as a vaccine for prophylaxis and immunotherapy of infectious diseases and tumors
|
|
CN101148661B
(zh)
*
|
2006-09-18 |
2013-01-02 |
中国医学科学院基础医学研究所 |
人乳头瘤病毒16型外壳蛋白病毒样颗粒及其制备方法和用途
|
|
US20090181078A1
(en)
|
2006-09-26 |
2009-07-16 |
Infectious Disease Research Institute |
Vaccine composition containing synthetic adjuvant
|
|
LT2486938T
(lt)
|
2006-09-26 |
2018-06-25 |
Infectious Disease Research Institute |
Vakcinos kompozicija, turinti sintetinio adjuvanto
|
|
US8968995B2
(en)
*
|
2008-11-12 |
2015-03-03 |
Oncohealth Corp. |
Detection, screening, and diagnosis of HPV-associated cancers
|
|
US8859218B2
(en)
*
|
2008-06-13 |
2014-10-14 |
Oncohealth Corp. |
In situ detection of early stages and late stages HPV infection
|
|
US8916342B2
(en)
|
2006-11-13 |
2014-12-23 |
Oncohealth Corp. |
Identification of high grade or ≧ CIN2 for early stages and late stages detection, screening, and diagnosis of human papillomavirus (HPV) and HPV-associated cancers
|
|
WO2008115631A2
(en)
*
|
2007-02-08 |
2008-09-25 |
University Of Louisville Research Foundation, Inc. |
Plant-produced compositions for treating papillomavirus infection and related methods
|
|
EA021391B1
(ru)
|
2007-03-02 |
2015-06-30 |
Глаксосмитклайн Байолоджикалс С.А. |
Способ индукции иммунного ответа, вакцинная композиция, ее применение и набор
|
|
US9364529B2
(en)
|
2007-04-29 |
2016-06-14 |
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. |
Truncated L1 protein of human papillomavirus type 18
|
|
EP2154147B1
(en)
|
2007-04-29 |
2015-10-07 |
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. |
A truncated l1 protein of human papillomavirus 16
|
|
DK2154149T3
(da)
*
|
2007-05-29 |
2019-10-14 |
Univ Xiamen |
En trunkeret l1-protein af human papillomavirus 6
|
|
US20100260792A1
(en)
*
|
2007-10-22 |
2010-10-14 |
University Of Rochester |
Respiratory syncytial virus vaccine based on chimeric papillomavirus virus-like particles or capsomeres
|
|
RU2494106C2
(ru)
*
|
2007-11-23 |
2013-09-27 |
Шанхай Зеран Биотекнолоджи Ко., Лтд. |
Гены, кодирующие главный капсидный белок l1 вируса папилломы человека, и их применение
|
|
GB0815872D0
(en)
|
2008-09-01 |
2008-10-08 |
Pasteur Institut |
Novel method and compositions
|
|
GB0820822D0
(en)
|
2008-11-13 |
2008-12-24 |
Inst Catala D Oncologia |
Novel product and processes
|
|
JP5830015B2
(ja)
|
2009-06-05 |
2015-12-09 |
インフェクシャス ディズィーズ リサーチ インスティチュート |
合成グルコピラノシル脂質アジュバント
|
|
EP2521914A4
(en)
|
2010-01-08 |
2013-07-10 |
Oncohealth Corp |
CELL-BASED HPV IMMUNOTESTS HAVE A HIGH PERFORMANCE FOR DIAGNOSIS AND SCANNING OF HPV ASSOCIATED CANCER
|
|
CN103596586A
(zh)
|
2011-04-08 |
2014-02-19 |
免疫设计公司 |
免疫原性组合物及使用所述组合物诱导体液和细胞免疫反应的方法
|
|
CN103732250A
(zh)
*
|
2011-06-14 |
2014-04-16 |
全球免疫股份有限公司 |
基于酵母的治疗或预防丁型肝炎病毒感染的组合物和方法
|
|
RU2610174C2
(ru)
|
2011-06-24 |
2017-02-08 |
Мерк Шарп И Доум Корп. |
Вакцинные составы против вируса папилломы человека (hpv), содержащие алюминиевый адъювант, и способы их получения
|
|
CA2847604A1
(en)
|
2011-09-08 |
2013-03-14 |
Uniqure Ip B.V. |
Removal of contaminating viruses from aav preparations
|
|
US11510875B2
(en)
|
2012-02-07 |
2022-11-29 |
Access To Advanced Health Institute |
Adjuvant formulations comprising TLR4 agonists and methods of using the same
|
|
CA2866582A1
(en)
|
2012-03-18 |
2013-09-26 |
Brigitte Desiree Alberte Colau |
Method of vaccination against human papillomavirus
|
|
HUE039215T2
(hu)
|
2012-05-16 |
2018-12-28 |
Immune Design Corp |
Vakcinák HSV-2-höz
|
|
EA032326B1
(ru)
|
2013-04-18 |
2019-05-31 |
Иммьюн Дизайн Корп. |
Монотерапия gla для применения в лечении рака
|
|
US9463198B2
(en)
|
2013-06-04 |
2016-10-11 |
Infectious Disease Research Institute |
Compositions and methods for reducing or preventing metastasis
|
|
CN104231060B
(zh)
*
|
2013-06-05 |
2018-05-15 |
厦门大学 |
人乳头瘤病毒l1l2衣壳蛋白相互作用位点及其应用
|
|
IL310015B1
(en)
|
2013-12-31 |
2025-10-01 |
Access To Advanced Health Inst |
Single vial formulation
|
|
JP7195148B2
(ja)
|
2016-05-16 |
2022-12-23 |
アクセス ツー アドバンスト ヘルス インスティチュート |
Ｔｌｒアゴニストを含有する製剤及び使用方法
|
|
JP7195147B2
(ja)
|
2016-05-16 |
2022-12-23 |
アクセス ツー アドバンスト ヘルス インスティチュート |
Ｐｅｇ化リポソームおよび使用方法
|
|
KR102472026B1
(ko)
|
2016-06-01 |
2022-11-30 |
액세스 투 어드밴스드 헬스 인스티튜트 |
사이징제를 함유하는 나노명반 입자
|
|
IL271384B2
(en)
|
2017-06-15 |
2025-02-01 |
Access To Advanced Health Inst |
Nanostructured lipid carriers and stable emulsions and their uses
|
|
KR102755593B1
(ko)
|
2017-09-08 |
2025-01-20 |
액세스 투 어드밴스드 헬스 인스티튜트 |
사포닌을 포함하는 리포솜 제형 및 사용 방법
|
|
JP7491932B2
(ja)
*
|
2018-12-28 |
2024-05-28 |
ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー |
操作されたｂ型肝炎コアポリペプチド
|
|
CA3141577A1
(en)
|
2019-05-25 |
2020-12-03 |
Infectious Disease Research Institute |
Composition and method for spray drying an adjuvant vaccine emulsion
|
|
CN114127295B
(zh)
*
|
2019-07-19 |
2024-05-14 |
神州细胞工程有限公司 |
嵌合的人乳头瘤病毒16型l1蛋白
|
|
CN114127099B
(zh)
*
|
2019-07-19 |
2024-04-19 |
神州细胞工程有限公司 |
嵌合的人乳头瘤病毒6型l1蛋白
|
|
CA3147850A1
(en)
|
2019-07-19 |
2021-01-28 |
Sinocelltech Ltd. |
Chimeric papillomavirus l1 protein
|
|
AU2020317321B2
(en)
|
2019-07-19 |
2023-07-27 |
Sinocelltech Ltd. |
Polyvalent immunogenicity composition for human papillomavirus
|
|
CN114127097B
(zh)
*
|
2019-07-19 |
2024-09-17 |
神州细胞工程有限公司 |
嵌合的人乳头瘤病毒56型l1蛋白
|
|
CR20220395A
(es)
|
2020-02-14 |
2022-10-27 |
Merck Sharp & Dome Llc |
Vacuna contra hpv
|
|
AU2021337493A1
(en)
|
2020-09-04 |
2023-05-18 |
Access To Advanced Health Institute |
Co-lyophilized rna and nanostructured lipid carrier
|
|
CN114539365B
(zh)
*
|
2020-11-26 |
2023-12-01 |
中国医学科学院基础医学研究所 |
一种改造的人乳头瘤病毒52型l1蛋白及其用途
|
|
CN114539363B
(zh)
*
|
2020-11-26 |
2023-12-01 |
中国医学科学院基础医学研究所 |
一种c端改造的人乳头瘤病毒11型l1蛋白及其用途
|
|
MX2023009456A
(es)
|
2021-02-11 |
2023-08-28 |
Glaxosmithkline Biologicals Sa |
Preparacion de la vacuna contra el vph.
|
|
US20240287545A1
(en)
|
2021-06-21 |
2024-08-29 |
Uniqure Biopharma B.V. |
Improved lysis procedures
|
|
TW202313658A
(zh)
|
2021-08-06 |
2023-04-01 |
美商默沙東有限責任公司 |
Hpv疫苗
|
|
JP2024532127A
(ja)
|
2021-08-19 |
2024-09-05 |
メルク・シャープ・アンド・ドーム・エルエルシー |
熱安定性脂質ナノ粒子およびその使用方法
|
|
IL319329A
(en)
|
2022-09-09 |
2025-05-01 |
Access To Advanced Health Inst |
Immunogenic vaccine composition incorporating saponin
|
|
AR132886A1
(es)
|
2023-06-09 |
2025-08-06 |
Merck Sharp & Dohme Llc |
Composiciones adyuvantes en nanoemulsión para vacunas contra el papilomavirus humano
|